Upon conversion of warrants
Sun Pharma Advanced Research Company granted 84,26,966 shares of Re 1 each upon conversion of an equivalent number of convertible warrants.
After the above allotment, the paid-up capital of the company increased from Rs. 26,34,52,000 (26,34,52,000 shares with a par value of Re. 1/- each fully paid) to Rs. 27 ,18,78,966/- (27,18,78,966 shares with a nominal value of Re. 1/- each fully paid up).
Powered by Capital Market – Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)